Concert Pharmaceutic (CNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Sales | 1,306 | 1,310 | 4,418 | 1,235 | 1,613 |
| Gross Profit | 1,306 | 1,310 | 4,418 | 1,235 | 1,613 |
| Operating Expenses | 10,177 | 10,055 | 12,026 | 8,961 | 8,132 |
| Operating Income | -8,871 | -8,745 | -7,608 | -7,726 | -6,519 |
| Interest Expense | 148 | 196 | 239 | 280 | 435 |
| Other Income | 17 | 14 | 15 | 16 | 4 |
| Pre-tax Income | -9,002 | -8,927 | -7,832 | -7,990 | -6,950 |
| Net Income Continuous | -9,002 | -8,927 | -7,832 | -7,990 | -6,950 |
| Net Income | $-9,002 | $-8,927 | $-7,832 | $-7,990 | $-6,950 |
| EPS Basic Total Ops | -0.48 | -0.36 | -0.43 | -0.45 | -0.76 |
| EPS Basic Continuous Ops | -0.48 | -0.37 | -0.43 | -0.45 | -0.76 |
| EPS Diluted Total Ops | -0.48 | -0.36 | -0.43 | -0.45 | -0.76 |
| EPS Diluted Continuous Ops | -0.48 | -0.37 | -0.43 | -0.45 | -0.76 |
| EBITDA(a) | $-8,549 | $-8,458 | $-7,052 | $-7,230 | $-6,204 |